Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Young patients with alopecia areata are satisfied with Janus kinase inhibitors, noting hair regrowth and improved quality of life.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Interleukin-6 may play a role in causing alopecia areata.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

5-aminolevulinic acid therapy reduces acne by decreasing fat production in skin cells.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

IL-10 may worsen alopecia areata instead of helping it.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

The hydrogel improves burn healing by promoting tissue growth and reducing inflammation.

Using a combination of AMD3100 and FK506 can speed up and improve wound healing in diabetic rats.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Ritlecitinib works well and is safe for treating alopecia areata.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Bimekizumab can improve scarring alopecia in severe psoriasis.